Minivelle 0.075 MG/Day Twice Weekly Transdermal System

RxCUI
1357007
RxNorm name
Minivelle 0.075 MG/Day Twice Weekly Transdermal System
Display name
Minivelle 0.075 MG/Day Twice Weekly Transdermal System
Full name
Minivelle 0.075 MG/Day Twice Weekly Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6c5c47ab-28ee-11e1-bfc2-0800200c9a66Minivelle 0.075 MG/Day Twice Weekly Transdermal System [PSN] · 84 HR estradiol 0.00313 MG/HR Transdermal System [Minivelle] [SBD] · 84 HR Minivelle 0.00313 MG/HR Transdermal System [SY] · Minivelle 0.075 MG per 24HR Twice Weekly Transdermal Patch [SY] · Minivelle 0.075 MG/Day Twice Weekly Transdermal System [SY]519These highlights do not include all the information needed to use MINIVELLE safely and effectively. See full prescribing information for MINIVELLE. MINIVELLE ® (estradiol transdermal system) Initial U.S. Approval: 197520240222